BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32612949)

  • 1. A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients.
    Wu S; Qiao Q; Li G
    Front Oncol; 2020; 10():871. PubMed ID: 32612949
    [No Abstract]   [Full Text] [Related]  

  • 2. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
    Jang BS; Kim IA
    Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
    Jang BS; Kim IA
    Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response Prediction.
    Wu S; Xu J; Li G; Jin X
    Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas.
    Yan D; Zhao Q; Du Z; Li H; Geng R; Yang W; Zhang X; Cao J; Yi N; Zhou J; Tang Z
    Sci Rep; 2022 Apr; 12(1):6698. PubMed ID: 35461367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway.
    Meng J; Li P; Zhang Q; Yang Z; Fu S
    Oncotarget; 2014 Jul; 5(13):4683-93. PubMed ID: 24970813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 8. Construction of a novel radiosensitivity- and ferroptosis-associated gene signature for prognosis prediction in gliomas.
    Xie Y; Xiao Y; Liu Y; Lu X; Wang Z; Sun S; Liu L; Tang X; Xiao H; Liu H
    J Cancer; 2022; 13(8):2683-2693. PubMed ID: 35711838
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data.
    Liu J; Han M; Yue Z; Dong C; Wen P; Zhao G; Wu L; Xia J; Bin Y
    Front Genet; 2020; 11():960. PubMed ID: 33014019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.
    Wang QW; Zhao Z; Bao ZS; Jiang T; Zhu YJ
    Am J Cancer Res; 2021; 11(4):1226-1246. PubMed ID: 33948355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Radiosensitivity Prediction Model Developed Based on Weighted Correlation Network Analysis of Hypoxia Genes for Lower-Grade Glioma.
    Du Z; Liu H; Bai L; Yan D; Li H; Peng S; Cao J; Liu SB; Tang Z
    Front Oncol; 2022; 12():757686. PubMed ID: 35280808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
    Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
    Front Oncol; 2019; 9():1433. PubMed ID: 31921684
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
    Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I
    Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
    Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
    Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
    Zhang C; Yu R; Li Z; Song H; Zang D; Deng M; Fan Y; Liu Y; Zhang Y; Qu X
    Cancer Manag Res; 2019; 11():4971-4984. PubMed ID: 31213913
    [No Abstract]   [Full Text] [Related]  

  • 18. PD-1 and PD-L1 Expression Predicts Radiosensitivity and Clinical Outcomes in Head and Neck Cancer and is Associated with HPV Infection.
    Lyu X; Zhang M; Li G; Jiang Y; Qiao Q
    J Cancer; 2019; 10(4):937-948. PubMed ID: 30854100
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
    Ye N; Jiang N; Feng C; Wang F; Zhang H; Bai HX; Yang L; Su Y; Huang C; Wanggou S; Li X
    J Cancer; 2019; 10(22):5536-5548. PubMed ID: 31632497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade Gliomas.
    Zeng F; Liu X; Wang K; Zhao Z; Li G
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2079-2086. PubMed ID: 31533943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.